Reuters exclusively reported that major Bayer shareholder Harris Associates came out in strong support of the drugmaker’s decision to suspend work on breaking up the diversified group, giving some breathing room to its embattled CEO.
Related stories
Exclusives | Europe
Read more
Berlin considers full Uniper exit, targets deal after summer
13 January 2025
Exclusives | Europe
Read more
Shein IPO: UK regulator decision slowed by NGO challenge
12 December 2024
Exclusives | Europe
Read more